Kosmala, Aleksander
Duell, Johannes
Schneid, Simone
Serfling, Sebastian E.
Higuchi, Takahiro
Weich, Alexander
Lapa, Constantin
Hartrampf, Philipp E.
Raderer, Markus
Einsele, Hermann
Buck, Andreas K.
Topp, Max S.
Schlötelburg, Wiebke
Werner, Rudolf A. http://orcid.org/0000-0003-3372-6046
Funding for this research was provided by:
Okayama University (RECTOR)
Japan Society for the Promotion of Science (22H03027)
Deutsche Forschungsgemeinschaft (453989101, 453989101, 507803309)
Universitätsklinikum Würzburg
Article History
Received: 10 August 2023
Accepted: 21 October 2023
First Online: 9 November 2023
Declarations
:
: This study was conducted according to the guidelines of the Declaration of Helsinki. The need for further ethical review and approval were waived by the local Ethics Committee due to the retrospective character of the study (waiver no. 20220414 01).
: Procedures were performed as part of clinical care. Informed consent was obtained from all subjects.
: RAW and AKB have received speaker honoraria from Novartis/AAA and PentixaPharm. RAW reports advisory board work for Novartis/AAA and Bayer. AKB is a member of the advisory board of PentixaPharm. All other authors declare no conflict of interest.